FDA Warns Exosome Maker for Marketing Outside Its IND

(MedPage Today) -- The FDA has warned Kimera Labs that it can't sell its exosome product for uses outside of its recently secured investigational new drug (IND) application. In a warning letter that was posted to the FDA's website last September...
Source: MedPage Today Public Health - Category: American Health Source Type: news